Pegloticase Combined With Methotrexate Maintains Efficacy for Gout at Year 1
Presenting at ACR 2022, researchers assessed the safety and efficacy of pegloticase with add-on methotrexate vs placebo for uncontrolled gout.
Presenting at ACR 2022, researchers assessed the safety and efficacy of pegloticase with add-on methotrexate vs placebo for uncontrolled gout.
The role of micro-RNAs in the pathophysiology of hand osteoarthritis was explored, using data from postmenopausal women.
Researchers sought to evaluate the impact of risankizumab vs placebo on health care-related quality of life and other patient-reported outcomes in patients with psoriatic arthritis.
Researchers examined trends of early- and late-onset pancreatic cancer across different sex and racial and ethnic groups in the US.
Important clinical considerations for clinicians treating asthma, rhinitis, and atopic dermatitis are presented.
Researchers compared maternal and perinatal outcomes in US pregnant patients with cirrhosis, noncirrhotic chronic liver disease (CLD), and without CLD.
Investigators assessed the impact of different sleep positions on the incidence of nocturnal acid reflux.
Researchers estimated the 10- and 30-year risk for cardiovascular disease in patients with serious mental illness.
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
Investigators assessed the impact of maternal antibiotic administration timing on infant gut colonization in babies delivered via cesarean section.